96 related articles for article (PubMed ID: 24169233)
1. Structure-activity relationship studies of thalidomide analogs with a taxol-like mode of action.
Pandit B; Hu Z; Chettiar SN; Zink J; Xiao Z; Etter JP; Bhasin D; Li PK
Bioorg Med Chem Lett; 2013 Dec; 23(24):6902-4. PubMed ID: 24169233
[TBL] [Abstract][Full Text] [Related]
2. Novel tubulin-polymerization inhibitor derived from thalidomide directly induces apoptosis in human multiple myeloma cells: possible anti-myeloma mechanism of thalidomide.
Iguchi T; Yachide-Noguchi T; Hashimoto Y; Nakazato S; Sagawa M; Ikeda Y; Kizaki M
Int J Mol Med; 2008 Feb; 21(2):163-8. PubMed ID: 18204782
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide (5HPP-33) suppresses microtubule dynamics and depolymerizes the microtubule network by binding at the vinblastine binding site on tubulin.
Rashid A; Kuppa A; Kunwar A; Panda D
Biochemistry; 2015 Mar; 54(12):2149-59. PubMed ID: 25747795
[TBL] [Abstract][Full Text] [Related]
4. A thalidomide analogue with in vitro antiproliferative, antimitotic, and microtubule-stabilizing activities.
Li PK; Pandit B; Sackett DL; Hu Z; Zink J; Zhi J; Freeman D; Robey RW; Werbovetz K; Lewis A; Li C
Mol Cancer Ther; 2006 Feb; 5(2):450-6. PubMed ID: 16505120
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of paclitaxel-mimics possessing only the oxetane D-ring and side chain structures.
Chen XX; Gao F; Wang Q; Huang X; Wang D
Fitoterapia; 2014 Jan; 92():111-5. PubMed ID: 24211350
[TBL] [Abstract][Full Text] [Related]
6. Taxol
Yang CH; Horwitz SB
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28792473
[TBL] [Abstract][Full Text] [Related]
7. Total synthesis of a library of designed hybrids of the microtubule-stabilising anticancer agents taxol, discodermolide and dictyostatin.
Paterson I; Naylor GJ; Fujita T; Guzmán E; Wright AE
Chem Commun (Camb); 2010 Jan; 46(2):261-3. PubMed ID: 20024345
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship of 4-azaheterocycle benzenesulfonamide derivatives as new microtubule-targeting agents.
Yang J; Zhou S; Ji L; Zhang C; Yu S; Li Z; Meng X
Bioorg Med Chem Lett; 2014 Nov; 24(21):5055-8. PubMed ID: 25278233
[TBL] [Abstract][Full Text] [Related]
9. Insight on [1,3]thiazolo[4,5-e]isoindoles as tubulin polymerization inhibitors.
Spanò V; Barreca M; Rocca R; Bortolozzi R; Bai R; Carbone A; Raimondi MV; Piccionello AP; Montalbano A; Alcaro S; Hamel E; Viola G; Barraja P
Eur J Med Chem; 2021 Feb; 212():113122. PubMed ID: 33401199
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of benzophenone-bearing diketopiperazine-type anti-microtubule agents.
Yamazaki Y; Sumikura M; Masuda Y; Hayashi Y; Yasui H; Kiso Y; Chinen T; Usui T; Yakushiji F; Potts B; Neuteboom S; Palladino M; Lloyd GK; Hayashi Y
Bioorg Med Chem; 2012 Jul; 20(14):4279-89. PubMed ID: 22727370
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR of C12-C13-oxazoline derivatives of epothilone A.
Pfeiffer B; Hauenstein K; Merz P; Gertsch J; Altmann KH
Bioorg Med Chem Lett; 2009 Jul; 19(14):3760-3. PubMed ID: 19433359
[TBL] [Abstract][Full Text] [Related]
12. Cell differentiation inducers derived from thalidomide.
Noguchi T; Miyachi H; Katayama R; Naito M; Hashimoto Y
Bioorg Med Chem Lett; 2005 Jul; 15(13):3212-5. PubMed ID: 15936192
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of 1-phenyl-1,2,3,4-dihydroisoquinoline compounds as tubulin polymerization inhibitors.
Zheng CH; Chen J; Liu J; Zhou XT; Liu N; Shi D; Huang JJ; Lv JG; Zhu J; Zhou YJ
Arch Pharm (Weinheim); 2012 Jun; 345(6):454-62. PubMed ID: 22415658
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluations of new analogs of 2-methoxyestradiol: inhibitors of tubulin and angiogenesis.
Solum EJ; Cheng JJ; Sørvik IB; Paulsen RE; Vik A; Hansen TV
Eur J Med Chem; 2014 Oct; 85():391-8. PubMed ID: 25108078
[TBL] [Abstract][Full Text] [Related]
15. 1,2,3-triazole analogs of combretastatin A-4 as potential microtubule-binding agents.
Odlo K; Fournier-Dit-Chabert J; Ducki S; Gani OA; Sylte I; Hansen TV
Bioorg Med Chem; 2010 Sep; 18(18):6874-85. PubMed ID: 20708408
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of anti-microtubule N-(2-Arylindol-7-yl)benzenesulfonamide derivatives and their antitumor mechanisms.
Chiou CT; Chen GS; Chen ML; Li H; Shi L; Huang XH; Dai WM; Chern JW
ChemMedChem; 2010 Sep; 5(9):1489-97. PubMed ID: 20672297
[No Abstract] [Full Text] [Related]
17. Discovery of CYT997: a structurally novel orally active microtubule targeting agent.
Burns CJ; Harte MF; Bu X; Fantino E; Joffe M; Sikanyika H; Su S; Tranberg CE; Wilson N; Charman SA; Shackleford DM; Wilks AF
Bioorg Med Chem Lett; 2009 Aug; 19(16):4639-42. PubMed ID: 19616947
[TBL] [Abstract][Full Text] [Related]
18. Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach.
Canales A; Rodríguez-Salarichs J; Trigili C; Nieto L; Coderch C; Andreu JM; Paterson I; Jiménez-Barbero J; Díaz JF
ACS Chem Biol; 2011 Aug; 6(8):789-99. PubMed ID: 21539341
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis inhibitors derived from thalidomide.
Noguchi T; Fujimoto H; Sano H; Miyajima A; Miyachi H; Hashimoto Y
Bioorg Med Chem Lett; 2005 Dec; 15(24):5509-13. PubMed ID: 16183272
[TBL] [Abstract][Full Text] [Related]
20. 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors.
Nien CY; Chen YC; Kuo CC; Hsieh HP; Chang CY; Wu JS; Wu SY; Liou JP; Chang JY
J Med Chem; 2010 Mar; 53(5):2309-13. PubMed ID: 20148562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
